G-DOC Plus - An integrative bioinformatics platform for precision medicine

BMC Bioinformatics

Volumn 17, Issue 1, 2016, Pages

  Bhuvaneshwar, Krithika ^a   Belouali, Anas ^a   Singh, Varun ^a   Johnson, Robert M ^a   Song, Lei ^a   Alaoui, Adil ^a   Harris, Michael A ^a   Clarke, Robert ^b   Weiner, Louis M ^b   Gusev, Yuriy ^a,b   Madhavan, Subha ^a,b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

Bioinformatics; Cloud computing; Genotype phenotype integration; Next generation sequencing; Outcomes research; Precision medicine; Translational research; Variant analysis

Indexed keywords

BIOINFORMATICS; BIOMARKERS; CLOUD COMPUTING; DATA INTEGRATION; DISEASES; GENE EXPRESSION; GENES; HTTP; IMAGE ANALYSIS; MAGNETIC RESONANCE IMAGING; MEDICAL IMAGING; MEDICINE; POPULATION STATISTICS;

CLINICAL INFORMATION; COMPUTATIONAL SCIENCE; HYPOTHESIS GENERATION; MOLECULAR SIGNATURES; NEXT-GENERATION SEQUENCING; OUTCOMES RESEARCH; TRANSLATIONAL RESEARCH; VARIANT ANALYSIS;

BIG DATA;

TRANSCRIPTOME;

BIOLOGY; DNA MICROARRAY; FACTUAL DATABASE; GENETICS; HUMAN; NEOPLASM; PERSONALIZED MEDICINE; PROCEDURES;

COMPUTATIONAL BIOLOGY; DATABASES, FACTUAL; HUMANS; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRECISION MEDICINE; TRANSCRIPTOME;

EID: 85007489252     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/s12859-016-1010-0     Document Type: Article

References (66)

1. Madhavan S, Gusev Y, Harris M, Tanenbaum DM, Gauba R, Bhuvaneshwar K, et al. G-DOC: a systems medicine platform for personalized oncology. Neoplasia. 2011;13:771-83.
2. Editorial. Method of the Year. Nature methods. 2008;5:1.
3. Schuster SC. Next-generation sequencing transforms today's biology. Nat Methods. 2008;5:16-8.
4. The 1000 genomes data. [http://www.1000genomes.org/] Accessed 7 Oct 2015.
5. Complete Genomics. [http://www.completegenomics.com] Accessed 9 Feb 2015.
6. Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, et al. NCBI GEO: archive for functional genomics data sets-update. Nucleic Acids Res. 2013;41:D991-995.
7. TCGA Research Network. [http://cancergenome.nih.gov/] Accessed 9 Feb 2015.
8. Madhavan S, Zenklusen JC, Kotliarov Y, Sahni H, Fine HA, Buetow K. Rembrandt: helping personalized medicine become a reality through integrative translational research. Mol Cancer Res. 2009;7:157-67.
9. Microarray data management system (caArray). [https://wiki.nci.nih.gov/display/caArray2/caArray] Accessed 23 Feb 2015.
10. Bhattacharya S, Andorf S, Gomes L, Dunn P, Schaefer H, Pontius J, et al. ImmPort: disseminating data to the public for the future of immunology. Immunol Res. 2014;58:234-9.
11. Vastrik I, D'Eustachio P, Schmidt E, Gopinath G, Croft D, de Bono B, et al. Reactome: a knowledge base of biologic pathways and processes. Genome Biol. 2007;8:R39.
12. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5:R80.
13. Amazon EC2. [http://aws.amazon.com/ec2/] Accessed 9 Feb 2015.
14. Amazon Web Services. [http://aws.amazon.com/] Accessed 26 Feb 2015.
15. Can big data and SQL get along? [http://www.simba.com/blog/sqlaccess-non-relational-sources-proliferating/] Accessed 9 Feb 2015.
16. NoSQL. [http://en.wikipedia.org/wiki/NoSQL] Accessed 9 Feb 2015.
17. MongoDB. [http://www.mongodb.org/] Accessed 9 Feb 2015.
18. CAP theorem. [http://en.wikipedia.org/wiki/CAP_theorem] Accessed 9 Feb 2015.
19. Mongo DB Document Databases. [https://www.mongodb.com/document-databases] Accessed 7 Oct 2015.
20. BSON. [http://bsonspec.org/] Accessed 23 Oct 2015.
21. Django. [https://en.wikipedia.org/wiki/Django_(web_framework)] Accessed 23 Oct 2015.
22. Digital Imaging and Communications in Medicine (DICOM). [http://dicom.nema.org/] Accessed 12 Mar 2015.
23. Oviyam. [http://oviyam.raster.in/] Accessed 12 Mar 2015.
24. Github. [https://github.com/] Accessed 9 Feb 2015.
25. Cleveland heart lab CYP2C19. [http://www.clevelandheartlab.com/wp-content/uploads/2013/09/CYP2C19-Practitioner-OnePager-CHL-D022.pdf] Accessed: 9 Feb 2015.
26. Affymetrix DMET console. [http://www.affymetrix.com/estore/browse/level_seven_software_products_only.jsp?productId=131559-1_1] Accessed.
27. Griffith M, Griffith OL, Coffman AC, et al. DGIdb-Mining the druggable genome. Nature methods. 2013;10(12):1209-10. doi:10.1038/nmeth.2689.
28. Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 2001;29:308-11.
29. Dean L. Clopidogrel therapy and CYP2C19 genotype. In: Medical genetics summaries. 2013.
30. Shuldiner AR, O'Connell JR, Bliden KP, Gandhi A, Ryan K, Horenstein RB, et al. Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy. JAMA. 2009;302:849-57.
31. Desta Z, Zhao X, Shin JG, Flockhart DA. Clinical significance of the cytochrome P450 2C19 genetic polymorphism. Clin Pharmacokinet. 2002;41:913-58.
32. Karnik P, Paris M, Williams BR, Casey G, Crowe J, Chen P. Two distinct tumor suppressor loci within chromosome 11p15 implicated in breast cancer progression and metastasis. Hum Mol Genet. 1998;7:895-903.
33. Callahan R, Campbell G. Mutations in human breast cancer: an overview. J Natl Cancer Inst. 1989;81:1780-6.
34. Dahiya R, Perinchery G, Deng G, Lee C. Multiple sites of loss of heterozygosity on chromosome 8 in human breast cancer has differential correlation with clinical parameters. Int J Oncol. 1998;12:811-6.
35. El Gammal AT, Bruchmann M, Zustin J, Isbarn H, Hellwinkel OJ, Kollermann J, et al. Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancer. Clin Cancer Res. 2010;16:56-64.
36. Complete Genomics Breast Cancer Dataset. [http://www.completegenomics.com/public-data/cancer-data/] Accessed: 26 Feb 2015.
37. Neel H, Gondran P, Weil D, Dautry F. Regulation of pre-mRNA processing by src. Curr Biol. 1995;5:413-22.
38. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498-504.
39. Cancer Gene Index. [https://wiki.nci.nih.gov/display/cageneindex/Cancer+Gene+Index+End+User+Documentation] Accessed: 26 Feb 2015.
40. Madhavan S, Gusev Y, Natarajan TG, Song L, Bhuvaneshwar K, Gauba R, et al. Genome-wide multi-omics profiling of colorectal cancer identifies immune determinants strongly associated with relapse. Front Genet. 2013;4:236.
41. Benjamini Y, Yekutieli D. The control of the false discovery rate in multiple testing under dependency. Ann Statist. 2001;29:1165-88.
42. Fortin Ensign SP, Mathews IT, Symons MH, Berens ME, Tran NL. Implications of Rho GTPase signaling in glioma cell invasion and tumor progression. Front Oncol. 2013;3:241.
43. Li Y, Wang D, Wang L, Yu J, Du D, Chen Y, et al. Distinct genomic aberrations between low-grade and high-grade gliomas of Chinese patients. PLoS One. 2013;8:e57168.
44. Rickman DS, Bobek MP, Misek DE, Kuick R, Blaivas M, Kurnit DM, et al. Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis. Cancer Res. 2001;61:6885-91.
45. Duffau H. Diffuse low-grade gliomas in adults. London: Springer; 2013.
46. Sawyer JR, Thomas JR, Teo C. Low-grade astrocytoma with a complex fourbreakpoint inversion of chromosome 8 as the sole cytogenetic aberration. Cancer Genet Cytogenet. 1995;83:168-71.
47. Felicella MM, Hagenkord JM, Kash SF, Powers MP, Berger MS, Perry A. A common 8q (MYC) amplification detected in a multifocal anaplastic astrocytoma by SNP array karyotyping. Clin Neuropathol. 2012;31:210-5.
48. Lopez-Gines C, Cerda-Nicolas M, Gil-Benso R, Pellin A, Lopez-Guerrero JA, Callaghan R, et al. Association of chromosome 7, chromosome 10 and EGFR gene amplification in glioblastoma multiforme. Clin Neuropathol. 2005;24:209-18.
49. Crespo I, Vital AL, Nieto AB, Rebelo O, Tao H, Lopes MC, et al. Detailed characterization of alterations of chromosomes 7, 9, and 10 in glioblastomas as assessed by single-nucleotide polymorphism arrays. J Mol Diagn. 2011;13:634-47.
50. Sturm D, Bender S, Jones DT, Lichter P, Grill J, Becher O, et al. Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge. Nat Rev Cancer. 2014;14:92-107.
51. Huhn SL, Mohapatra G, Bollen A, Lamborn K, Prados MD, Feuerstein BG. Chromosomal abnormalities in glioblastoma multiforme by comparative genomic hybridization: correlation with radiation treatment outcome. Clin Cancer Res. 1999;5:1435-43.
52. Kuo KT, Guan B, Feng Y, Mao TL, Chen X, Jinawath N, et al. Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas. Cancer Res. 2009;69:4036-42.
53. Gusev Y, Riggins RB, Bhuvaneshwar K, Gauba R, Sheahan L, Clarke R, et al. In silico discovery of mitosis regulation networks associated with early distant metastases in estrogen receptor positive breast cancers. Cancer Informat. 2013;12:31-51.
54. Clark K, Vendt B, Smith K, Freymann J, Kirby J, Koppel P, et al. The Cancer Imaging Archive (TCIA): maintaining and operating a public information repository. J Digit Imaging. 2013;26:1045-57.
55. Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2:401-4.
56. Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Varambally R, Yu J, Briggs BB, et al. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia. 2007;9:166-80.
57. Elgamal OA, Park JK, Gusev Y, Azevedo-Pouly AC, Jiang J, Roopra A, et al. Tumor suppressive function of mir-205 in breast cancer is linked to HMGB3 regulation. PLoS One. 2013;8:e76402.
58. Lin L, Yao Z, Bhuvaneshwar K, Gusev Y, Kallakury B, Yang S, et al. Transcriptional regulation of STAT3 by SPTBN1 and SMAD3 in HCC through cAMP-response element-binding proteins ATF3 and CREB2. Carcinogenesis. 2014;35:2393-403.
59. Zhi X, Lin L, Yang S, Bhuvaneshwar K, Wang H, Gusev Y, et al. betaII-Spectrin (SPTBN1) suppresses progression of hepatocellular carcinoma and Wnt signaling by regulation of Wnt inhibitor kallistatin. Hepatology. 2015;61:598-612.
60. Feizi A, Bordel S. Metabolic and protein interaction sub-networks controlling the proliferation rate of cancer cells and their impact on patient survival. Sci Rep. 2013;3:3041.
61. Kolassa JE, Seifu Y. Nonparametric multivariate inference on shift parameters. Acad Radiol. 2013;20:883-8.
62. BCHB-594 Translational Bioinformatics. [http://courses.georgetown.edu/index.cfm?Action=View&CourseID=BCHB-594&AcademicYear=2013&AcademicTerm=FallSpring] Accessed: 9 Feb 2015.
63. Athey BD, Braxenthaler M, Haas M, Guo Y. tranSMART: an open source and community-driven informatics and data sharing platform for clinical and translational research. AMIA Jt Summits Transl Sci Proc. 2013;2013:6-8.
64. Canuel V, Rance B, Avillach P, Degoulet P, Burgun A. Translational research platforms integrating clinical and omics data: a review of publicly available solutions. Brief Bioinform. 2015;16(2):280-90.
65. Muirhead LJ. Surgical systems biology and personalized longitudinal phenotyping in critical care. Pers Med. 2012;9:593-608.
66. Chen X, Sun X, Hoshida Y. Survival analysis tools in genomics research. Hum Genomics. 2014;8:21.